Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asim Saha

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Blood|September 20, 2019
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHDBrent H Koehn, Asim Saha, Cameron McDonald-Hyman, et al.
Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.
The Journal of Clinical Investigation|August 15, 2018
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host diseaseCameron McDonald-Hyman, James T Muller, Michael Loschi, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Nature Medicine|November 14, 2018
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockadeZiming Wang, Ethan G Aguilar, Jesus I Luna, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Blood|September 20, 2019
Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHDBrent H Koehn, Asim Saha, Cameron McDonald-Hyman, et al.
Blood|September 25, 2020
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responsesGovindarajan Thangavelu, Chao Wang, Michael Loschi, et al.
The Journal of Clinical Investigation|August 15, 2018
The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host diseaseCameron McDonald-Hyman, James T Muller, Michael Loschi, et al.
Blood|July 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host diseaseLie Ma, Brent H Koehn, Michael C Zaiken, et al.
Blood|February 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomesMichael C Zaiken, Ryan Flynn, Katelyn G Paz, et al.
Nature Medicine|November 14, 2018
Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockadeZiming Wang, Ethan G Aguilar, Jesus I Luna, et al.
The Journal of Clinical Investigation|June 14, 2016
Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethalityAsim Saha, Roddy S O'Connor, Govindarajan Thangavelu, et al.
Pageof 7